FDA recall D-1064-2016

Product

Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612

Reason for recall

Failed Content Uniformity Specifications.

Distribution

Nationwide and Puerto Rico

Key facts

Status

Terminated

Initiation date

2016-05-10

Report date

2016-07-13

Termination date

2017-12-06

Voluntary/Mandated

Voluntary: Firm initiated

Location

Waco, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1064-2016